Xylem/$XYL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Xylem

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.

Ticker

$XYL

Primary listing

NYSE

Industry

Machinery

Employees

23,000

Xylem Metrics

BasicAdvanced
$32B
35.33
$3.71
1.11
$1.52
1.22%

What the Analysts think about Xylem

Analyst ratings (Buy, Hold, Sell) for Xylem stock.

Bulls say / Bears say

Xylem's acquisition of Evoqua Water Technologies in May 2023 for $7.5 billion positions it as the world's largest pure-play water technology company, potentially enhancing its market share and revenue streams. (businesswire.com)
The company's revenue for 2023 totaled $7.4 billion, exceeding the reported basis by 33%, indicating strong financial performance and growth potential. (businesswire.com)
Xylem's innovative initiatives, such as the Reuse Brew project launched in May 2024, demonstrate its commitment to sustainable solutions and technological advancement, potentially attracting environmentally conscious investors. (businesswire.com)
Spruce Point Capital Management issued a 'Strong Sell' opinion on Xylem in August 2023, citing concerns about the company's financial health and the integration of Evoqua, suggesting potential downside risks. (businesswire.com)
The Law Offices of Howard G. Smith announced an investigation into Xylem in October 2023 for possible violations of federal securities laws, which could lead to legal challenges and financial penalties. (businesswire.com)
Analysts have expressed concerns about Xylem's ability to meet aggressive growth expectations post-Evoqua acquisition, with some predicting a potential 30% to 45% long-term downside risk to the company's share price. (businesswire.com)
Data summarised monthly by Lightyear AI. Last updated on 13 Jul 2025.

Xylem Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Xylem Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XYL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs